920 related articles for article (PubMed ID: 7882322)
1. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats.
Kawamori T; Tanaka T; Ohnishi M; Hirose Y; Nakamura Y; Satoh K; Hara A; Mori H
Cancer Res; 1995 Sep; 55(18):4053-8. PubMed ID: 7664279
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
Tanaka T; Kojima T; Suzui M; Mori H
Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
5. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
[TBL] [Abstract][Full Text] [Related]
6. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
8. Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats.
Kawamori T; Tanaka T; Hirose Y; Satoh K; Hara A; Torihara M; Tamai Y; Yamahara J; Mori H
Cancer Lett; 1995 Jun; 92(2):159-65. PubMed ID: 7600526
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hirose Y; Ohnishi M; Mori H
Carcinogenesis; 1996 Feb; 17(2):369-72. PubMed ID: 8625465
[TBL] [Abstract][Full Text] [Related]
10. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
Femia AP; Dolara P; Caderni G
Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
[TBL] [Abstract][Full Text] [Related]
11. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
12. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models.
Au A; Li B; Wang W; Roy H; Koehler K; Birt D
Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869
[TBL] [Abstract][Full Text] [Related]
13. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats.
Miyamoto S; Kohno H; Suzuki R; Sugie S; Murakami A; Ohigashi H; Tanaka T
Oncol Rep; 2006 May; 15(5):1169-73. PubMed ID: 16596181
[TBL] [Abstract][Full Text] [Related]
14. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats.
Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T
Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y
J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.
Tanaka T; Shimizu M; Kohno H; Yoshitani S; Tsukio Y; Murakami A; Safitri R; Takahashi D; Yamamoto K; Koshimizu K; Ohigashi H; Mori H
Life Sci; 2001 Sep; 69(16):1935-45. PubMed ID: 11693274
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
Janakiram NB; Steele VE; Rao CV
Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
[TBL] [Abstract][Full Text] [Related]
19. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats.
Tanaka T; Kohno H; Shimada R; Kagami S; Yamaguchi F; Kataoka S; Ariga T; Murakami A; Koshimizu K; Ohigashi H
Carcinogenesis; 2000 Jun; 21(6):1183-9. PubMed ID: 10837008
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
